Concepedia

Nataliya Volkova

NV

12

Publications

1.4K

Citations

11

H-Index

2002

Active since

Affiliations

Emory University(Current)

Vertex Pharmaceuticals (United States)

Cystic Fibrosis Trust

Centers for Disease Control and Prevention

Vertex Pharmaceuticals (United Kingdom)

Nataliya Volkova is an author at Emory University specializing in medicine, epidemiology, and hemodialysis.

Top concepts

MedicineEpidemiologyNephrologyHemodialysisPublic HealthHealth DisparitiesRacial DisparitiesChronic Kidney DiseaseHealthObesity

Publications per year

2002–2023

12

Publications

12

Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries

Nataliya Volkova, Kristin A. Moy, Jennifer Evans et al. · Journal of Cystic Fibrosis · 2019 · 244 citations

Neighborhood Poverty and Racial Disparities in Kidney Transplant Waitlisting

Rachel E. Patzer, Sandra Amaral, Haimanot Wasse et al. · Journal of the American Society of Nephrology · 2009 · 215 citations · Full text

Neighborhood Poverty, Health Care Disparity, Population Health Sciences +16

Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor

Leona Bessonova, Nataliya Volkova, Mark Higgins et al. · Thorax · 2018 · 205 citations · Full text

Neighborhood Poverty and Racial Differences in ESRD Incidence

Nataliya Volkova, William McClellan, Mitchel Klein et al. · Journal of the American Society of Nephrology · 2007 · 193 citations · Full text

Neighborhood Poverty, Health Disparities, Social Determinants Of Health +16

Temporal Changes in Prevalence of Antimicrobial Resistance in 23 U.S. Hospitals

Scott K. Fridkin, Holly A. Hill, Nataliya Volkova et al. · Emerging infectious diseases · 2002 · 133 citations · Full text

Rows per page

1–5 of 12